Two recent studies that included individuals with and without type 2 diabetes found that GLP-1 contributed ~50% of the glucose-lowering and insulin-stimulatory effects of DPP-4 inhibitors [2, 18]
Studies focus on its ability to amplify natural growth hormone pulses through pituitary stimulation
However, some individuals may experience mild side effects such as: Slight discomfort or bruising at the injection site Temporary lightheadedness or dizziness A cool sensation in the arm during infusion Serious side effects are rare, but if you have any underlying health conditions, its always best to consult with a healthcare professional before starting IV therapy
They do not offer popular research peptides like BPC-157 , TB-500 , or ipamorelin
Roles of oxidative stress and Nrf2 signaling in pathogenic and non-pathogenic cells: A possible general mechanism of resistance to therapy
Just eating when hungry, stopping when full, and walking more